O12.4. EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE ON BONE STATUS IN OBESE, NON-DIABETIC, ANTIPSYCHOTIC-TREATED SCHIZOPHRENIA SPECTRUM PATIENTS
Eriksson, Robert, Broberg, Brian V, Ishoy, Pelle Lau, Bak, Nikolaj, Andersen, Ulrik B, Jørgensen, Niklas R, Knop, Filip K, Ebdrup, BjornVolume:
45
Language:
english
Journal:
Schizophrenia Bulletin
DOI:
10.1093/schbul/sbz021.268
Date:
April, 2019
File:
PDF, 98 KB
english, 2019